THE RESPONSE TO 1-44 G R W H HORMONE RELEASING FACTOR (1-44 GRF) WITH THE SLEEP SECRETION AND THE RESPONSES
TO PHARHACOLffiIC STIMULI.
GH secretion was evaluated in 54 short patients with mean growth retardation of 3.3 0.96 SD ( 32 M and 22 F aged 5 to 19 years), comparing their peak response to GRF 1-44 Sanofi 2 p g l k g IV (GRF P) and to 2 conventional pharrnacologic stimuli (arginine, insulin, glucagon, ornithine) (PS P) with the peak value of their sleep secretion (SS P). GRF P was more significantly correlated with PS P(r = 0.53, p < 0.001) than with SS P (r = 0.33, p<0.02).
The patients have been classified into 5 groups according as usually to the sleep and pharmacologic GH levels: group I = 2fi endocrinoloqically normal with both PS and SS peaks) 10 ng/ml; group XI = 5 completely GH deficient with both PS and SS peaks < 6 ng/ml; group I11 = 8 partially deficient with both PS and SS P 6 to 10 ng/ml; group IV = 9 with normal SS P and low PS P; group V = 6 with low SS P and normal PS P.
GRF P (R ' SEM) was 39 ' 5.6 ng/ml in group I , 12 ' 3.4 in group 11, 24 ' 3.7 in group 111, 12 ' 5.0 in group IV and 23 '5.3 nglml in group V. It was significantly higher in group I than In all others ( I vs I1 and vs IV p < 0.001, I vs I11 and vs V p < 0.05). However there was a large overlap of the GRF P between the 5 groups. It is concluded that the GRF test contributes to the evaluation of GH secretion but probably does not improve the definition of atypical deficiencies.
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GH SECRETION DURING SLEEP AND GRF-STIMULATION IN GH-DEFICIENT AND SHORT NORMAL CHILDREN
In 22 short-statured children GH was determined every 20 minutes frm 20:OO to 8:00 with continous EEG registration to demonstrate stage 4 sleep. Peak and mean GH values were analyzed. At 8:00 a bolus of 1 pg/kg GRF 1-44 was given and GH measured every 15 minutes. Group A (n.12) had been previously diagnosed as GHdeficient (GHO)(peak GH < 6 ng/ml in 2 independent tests, height and growth rate < -2 SDS). These children had been treated with GH for 1.5-12 years and were off treatment for > 6 months when reexamined. Group B (n=2) had been diagnosed and treated as GHD but showed normal gro~th velocity after cessation of therapy. Both had reached Tanner 111 and might be classified as transient GHD. Group C consisted L. Gelander*, K . Albertsson-Wlkland 68 Department of Pediatrics I1 and Physiology University of GGteborg, GGteborg, Sweden GROWTH HORMONE (Gtl) RCLCASE AFTER GROWTll IIOHMONE RE-LEASING HORMONE(GRt1) CORRELATES TO CNDOGCNOUS 24-tl-Gll SECRETION IN 38 SHORT CHILDREN In 38 short children we followed the endogenous GH-secretion f11r 2 4 h (sampling intervals of 20 mln).This was immediately followed by an i v inj. of lug/kg of GRH 1-27. GI1 was cstlrnatcd cvcry 151nln the following two hours. The aim was to study if the spontaneous GH-secretion, measured during the 24-h-period, had any relation to or influenced on the GH-release induced by GRII. Patients: The chron. age or the children ranged 3-13y. 32 were prcpubertal and 7 showed signs of early puberty. 6 children had a Gliresponse to insulin-arginine test below 14mU/1 (classically GtI-deD.
All children were otherwise considered healthy.
Results: In 32 children the 24-h-GH-secretion varled bctween 54-1500 niU AUC(Area Under the Curve) over basal and with a mean of 4.1-26mU/1. The Gti-def. ch~ldren showed a dlmlnshed 24-h-GH-secrc.-tlon. An increased GH-secretion after GRH was found in all buL orle of the 30 children. Max.leve1 of 107 "l4m~/1, range 17-296mU/1. [\ high endogenous 24-h-GH secretion after GRll when estimated eitllcr as AUC over basal(r=0.47;p<0.01) or as mean of the 24-h-period(r:: 0.40;p<0.01). The endogenous GH-secretion measured durlng 3h beri~re CRH inj. did not influence on the GH-response to GRH. However, very few of the children had endogenous secretion during these rnornln~jli. Conclusions: The correlation between a hlgh endogenous 24-h-GtI-secrction and a high GH-response to GRH, indicates that thc GRII LesL may he a useful tool to estimate the ability to release GH I~I sliort children. The GHRF test is thought to be able to differentiate pitutary from hypothalamic defects in GH-deficient patients. Our purpose uas to verify if the informathn obtained via GHRF test uas in agreement uith that of by the TRH and LHRH tests performed in pituitary subjects followed from 2 to 12 yrs. Subjects: 36 pituitary patients subdivided into 3 groups: I) 11 uith normal puberty; 11) 9 uith pharmacologically induced puberty; 111) 16 prepubertal with bane age ( 12 yrs. GRF test (3 ug/Kg iv): a peak 24 ng/ml uas present in 10 subjects in group 1 (91% hypothalamic defect). 3 in group I1 (33% hypothalamic), 9 in group I11 (56% of 8 children in whom GH rose above 8 ng/ml in at least one conventional test. hypothalamic). TRH test (100 ug iv): group I normal response, no subject neeccd Table 1 gives meant E M for chronological age (CA), bone age @A), height re~lacement theraov: arouo 11 onlv one uith a normal h v o o t h a l a m o -o i t u i t a r v -t t~v -. . . .
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and growth velocity (cmlyear), peak (P) and mean (M) GH values during sleep roidal axis, and 8 with hypothyroidism and a delayed and prolonged TSH resporlse and peak GH after GRF (nglml). Individual values in group 8.
( lo test the hypothesis of an hypothalaaic origin of the growth retardation observed in thalassemic children at the time of puberty, 18 males and 6 females. aged 9 to 20 years, have been studied under high-regimen blood transfusion and desferrioxamine therapy for the GH response to GRF (2uglkg. 1-44 NH2, Sanofi). conventional tests and sleep. Pubertal stages according to Tanner rere as follows: 6 M and 4 F at stage 1. 8 M at stage 2 and 4 M and 2 F at stage 3 or aore. 13 1 and 5 F shoued evidences of hypogonadotropic hypogonadism. The conventional test responses uere normal in 17 and lau in 7 patients. A blunted response to GRF was seen in 2 patients uhich previously shou normal pharmacological response. The GH nocturnal peak uas above 20 uI/ml in 14 patients. 8 have a decreased nocturnal secretion in contrast to normal GRF response. The nean values of the nocturnaland GRF-induced peaks uere belou normal for the age. There was no correlation between the conventional GH response and GRF or sleep response. The nocturnal response was correlated uith the GRF-induced peak but not uith either bone-age retardation. grouth velocity or ferritin blood level. In conclusion thalassemic children shou evidences of GH dysfunction suggesting a priaary hypothalamic dysfunction andlor an secondary effect of hypogonadism on the GH secretion likely related to hemosiderosis.
After cranial irradiation for acute lymphoblastic lwkrmia(ALL) low GH response to pharmacological stimlation and/or &ring sleep has been considered as evidence of neurosecretory dysfunction.In order to further evaluate this condition, the GH response to hpCRF 1-44 (2 pg/kg IV) was studied in 19 prepubertal children irradiated at a m a n CA of 4 10/12 + 8/12 yr (m + sem) with 2400 rad (12x200 rad/l6 days). They were eva--luated after a mean interval time of 4 R/12 + 3/12 yr and compared to an age mtchcd group with constitutional short stature (CSS). height -3.0'0.7 -3.7/-3.4 CA 14.9'0.9 14.9/14.6 (n) GH-AITT peak(ng/ml) GH-GRF peak(ndm1) SmC/IGTI((l/ml) Irradiated (19) After irradiation the individual Gti responses to GRF, although not correlated with the GH-AITT peak or SIC levels, were decreased in 17/19 cases. Furthermore in 4 cases with n o m l qrmth rotes and GII-AITT peaks (9-22 ng/ml) a decreased response to GRF (12-19 nq/ml) was ohserved. These results suggest that an impaired GH response to GRF : 1) is a frequent finding after cranial irradiation in ALL ; 2) and may he the only sign of GH nwrosecretory dysfunction. 
